Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP929003.RACtCfn-nrCFI2dsCe_3kM1PMiOulQjv-EIIi7tjqpoUM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP929003.RACtCfn-nrCFI2dsCe_3kM1PMiOulQjv-EIIi7tjqpoUM130_assertion type Assertion NP929003.RACtCfn-nrCFI2dsCe_3kM1PMiOulQjv-EIIi7tjqpoUM130_head.
- NP929003.RACtCfn-nrCFI2dsCe_3kM1PMiOulQjv-EIIi7tjqpoUM130_assertion description "[One hundred and sixty-two chemotherapy-na�ve patients with locally advanced/metastatic NSCLC who received front-line chemotherapy were included in this retrospective study and their clinical outcome data was analyzed according to EGFR and K-RAS mutation status of their tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929003.RACtCfn-nrCFI2dsCe_3kM1PMiOulQjv-EIIi7tjqpoUM130_provenance.
- NP929003.RACtCfn-nrCFI2dsCe_3kM1PMiOulQjv-EIIi7tjqpoUM130_assertion evidence source_evidence_literature NP929003.RACtCfn-nrCFI2dsCe_3kM1PMiOulQjv-EIIi7tjqpoUM130_provenance.
- NP929003.RACtCfn-nrCFI2dsCe_3kM1PMiOulQjv-EIIi7tjqpoUM130_assertion SIO_000772 19854533 NP929003.RACtCfn-nrCFI2dsCe_3kM1PMiOulQjv-EIIi7tjqpoUM130_provenance.
- NP929003.RACtCfn-nrCFI2dsCe_3kM1PMiOulQjv-EIIi7tjqpoUM130_assertion wasDerivedFrom befree-20140225 NP929003.RACtCfn-nrCFI2dsCe_3kM1PMiOulQjv-EIIi7tjqpoUM130_provenance.
- NP929003.RACtCfn-nrCFI2dsCe_3kM1PMiOulQjv-EIIi7tjqpoUM130_assertion wasGeneratedBy ECO_0000203 NP929003.RACtCfn-nrCFI2dsCe_3kM1PMiOulQjv-EIIi7tjqpoUM130_provenance.